Oruka Therapeutics (ORKA) Non-Current Deffered Revenue (2010 - 2018)
Oruka Therapeutics' (ORKA) quarterly Non-Current Deffered Revenue came in at $4000.0 in Q3 2018, down 84.0% year-on-year from $25000.0 in Q3 2017, and down 55.56% quarter-over-quarter from $9000.0 in Q2 2018.
Oruka Therapeutics (ORKA) Non-Current Deffered Revenue (2010 - 2018) Analysis & Trends
Oruka Therapeutics' Non-Current Deffered Revenue history runs 9 years deep, the most recent figure standing at $4000.0 for Q3 2018.
- On a quarterly basis, Non-Current Deffered Revenue fell 84.0% year-over-year to $4000.0 in Q3 2018; TTM through Sep 2018 was $4000.0, a 84.0% decrease from a year earlier, with the FY2017 full-year figure at $20000.0, down 48.72% from the prior year.
- Non-Current Deffered Revenue eased to $4000.0 in Q3 2018 per ORKA's latest filing, from $9000.0 in the prior quarter.
- Across five years, Non-Current Deffered Revenue topped out at $47000.0 in Q2 2016 and bottomed at $1000.0 in Q1 2014.
- The 5-year median for Non-Current Deffered Revenue is $12000.0 (2018), against an average of $17375.0.
- Across the five-year window, Non-Current Deffered Revenue slumped 87.5% in 2014 and surged 4600.0% in 2016, its largest moves.
- Year by year, Non-Current Deffered Revenue stood at $3000.0 in 2014, then sank by 66.67% to $1000.0 in 2015, then surged by 3800.0% to $39000.0 in 2016, then slumped by 48.72% to $20000.0 in 2017, then slumped by 80.0% to $4000.0 in 2018.
- Per Business Quant, the three latest ORKA Non-Current Deffered Revenue figures stand at $4000.0 (Q3 2018), $9000.0 (Q2 2018), and $15000.0 (Q1 2018).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 225.10 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Oruka Therapeutics | 36.09 Mn | -795.06 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | 4,000.00 |
| Jun 30, 2018 | 9,000.00 |
| Mar 31, 2018 | 15,000.00 |
| Dec 31, 2017 | 20,000.00 |
| Sep 30, 2017 | 25,000.00 |
| Jun 30, 2017 | 30,000.00 |
| Mar 31, 2017 | 35,000.00 |
| Dec 31, 2016 | 39,000.00 |
| Sep 30, 2016 | 43,000.00 |
| Jun 30, 2016 | 47,000.00 |
| Jun 30, 2015 | 1,000.00 |
| Mar 31, 2015 | 1,000.00 |
| Dec 31, 2014 | 3,000.00 |
| Sep 30, 2014 | 3,000.00 |
| Jun 30, 2014 | 2,000.00 |
| Mar 31, 2014 | 1,000.00 |
| Dec 31, 2013 | 1,000.00 |
| Jun 30, 2013 | 3,000.00 |
| Mar 31, 2013 | 8,000.00 |
| Dec 31, 2012 | 16,000.00 |